Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared HolzUpside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.


 

Latest Mizuho News

See all news
Mizuho Financial Group launches strategic technology and operations center in Pune

Mizuho Financial Group launches strategic technology and operations center in Pune

May 21, 2026
A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

May 19, 2026
Why biotechnology stocks have more room to run

Why biotechnology stocks have more room to run

May 12, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue